Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression

Leukemia Research

Volumn 33, Issue 12, 2009, Pages 1684-1695

  Lambrou, George I ^a   Vlahopoulos, Spiros ^a   Papathanasiou, Chrisanthi ^a   Papanikolaou, Maria ^a   Karpusas, Michael ^b   Zoumakis, Emmanouil ^a   Tzortzatou Stathopoulou, Fotini ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Univ Research Inst for the Study and Treatment of Childhood Genetic and Malignant Diseases   (Greece)

Author keywords

Biphasic; CCRF CEM; Differential gene expression; Mitogenic; Prednisolone

Indexed keywords

PREDNISOLONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; MICROARRAY ANALYSIS; MITOGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR NECROSIS;

BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; GENE EXPRESSION; HUMANS; MITOGENS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISOLONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 70249146146     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.04.018     Document Type: Article

References (56)

1. Tissing W.J., Meijerink J.P., den Boer M.L., Brinkhof B., van Rossum E.F., van Wering E.R., et al. Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia. Clin Cancer Res 11 (2005) 6050-6056
2. Den Boer M.L., Harms D.O., Pieters R., Kazemier K.M., Gobel U., Korholz D., et al. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol 21 (2003) 3262-3268
3. Russcher H., Smit P., van den Akker E.L., van Rossum E.F., Brinkmann A.O., de Jong F.H., et al. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. J Clin Endocrinol Metabol 90 (2005) 5804-5810
4. Kofler R., Schmidt S., Kofler A., and Ausserlechner M.J. Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia. J Endocrinol 178 (2003) 19-27
5. Takada Y., Kobayashi Y., and Aggarwal B.B. Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. J Biol Chem 280 (2005) 17203-17212
6. Medh R.D., Webb M.S., Miller A.L., Johnson B.H., Fofanov Y., Li T., et al. Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis. Genomics 81 (2003) 543-555
7. Ausserlechner M.J., Obexer P., Wiegers G.J., Hartmann B.L., Geley S., and Kofler R. The cell cycle inhibitor p16(INK4A) sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levels. J Biol Chem 276 (2001) 10984-10989
8. Thompson E.B., and Johnson B.H. Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells. Recent Prog Horm Res 58 (2003) 175-197
9. Kofler R. The molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells. Histochem Cell Biol 114 (2000) 1-7
10. Wissink S., van Heerde E.C., Schmitz M.L., Kalkhoven E., van der Burg B., Baeuerle P.A., et al. Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor. J Biol Chem 272 (1997) 22278-22284
11. Palmer L.A., and Harmon J.M. Biochemical evidence that glucocorticoid-sensitive cell lines derived from the human leukemic cell line CCRF-CEM express a normal and a mutant glucocorticoid receptor gene. Cancer Res 51 (1991) 5224-5231
12. Powers J.H., Hillmann A.G., Tang D.C., and Harmon J.M. Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and -resistant human leukemic cells. Cancer Res 53 (1993) 4059-4065
13. Norman M.R., and Thompson E.B. Characterization of a glucocorticoid-sensitive human lymphoid cell line. Cancer Res 37 (1977) 3785-3791
14. Schmidt S., Rainer J., Riml S., Ploner C., Jesacher S., Achmuller C., et al. Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. Blood 107 (2006) 2061-2069
15. Tudhope S.J., Catley M.C., Fenwick P.S., Russell R.E., Rumsey W.L., Newton R., et al. The role of IkappaB kinase 2, but not activation of NF-kappaB, in the release of CXCR3 ligands from IFN-gamma-stimulated human bronchial epithelial cells. J Immunol 179 (2007) 6237-6245
16. Miyazato A., Ueno S., Ohmine K., Ueda M., Yoshida K., Yamashita Y., et al. Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood 98 (2001) 422-427
17. Yang Y.H., and Speed T. Design issues for cDNA microarray experiments. Nat Rev 3 (2002) 579-588
18. Tindall E.A., Speight G., Petersen D.C., Padilla E.J., and Hayes V.M. Novel Plexor SNP genotyping technology: comparisons with TaqMan and homogenous MassEXTEND MALDI-TOF mass spectrometry. Hum Mut 28 (2007) 922-927
19. Watson J.V., Chambers S.H., and Smith P.J. A pragmatic approach to the analysis of DNA histograms with a definable G1 peak. Cytometry 8 (1987) 1-8
20. Ormerod M.G., Payne A.W., and Watson J.V. Improved program for the analysis of DNA histograms. Cytometry 8 (1987) 637-641
21. Wu W., Xing E.P., Myers C., Mian I.S., and Bissell M.J. Evaluation of normalization methods for cDNA microarray data by k-NN classification. BMC Bioinformatics 6 (2005) 191
22. Storey J.D., and Tibshirani R. Statistical methods for identifying differentially expressed genes in DNA microarrays. Methods Mol Biol 224 (2003) 149-157
23. Reyal F., Stransky N., Bernard-Pierrot I., Vincent-Salomon A., de Rycke Y., Elvin P., et al. Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes-a study of 130 invasive ductal breast carcinomas. Cancer Res 65 (2005) 1376-1383
24. Sturn A., Quackenbush J., and Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics 18 (2002) 207-208
25. Quackenbush J. Computational analysis of microarray data. Nat Rev 2 (2001) 418-427
26. Cole S.W., Yan W., Galic Z., Arevalo J., and Zack J.A. Expression-based monitoring of transcription factor activity: the TELiS database. Bioinformatics 21 (2005) 803-810
27. Maximo V., Lima J., Soares P., Silva A., Bento I., and Sobrinho-Simoes M. GRIM-19 in health and disease. Adv Anat Pathol 15 (2008) 46-53
28. Pruett S.B., Fan R., and Zheng Q. Characterization of glucocorticoid receptor translocation, cytoplasmic IkappaB, nuclear NFkappaB, and activation of NFkappaB in T lymphocytes exposed to stress-inducible concentrations of corticosterone in vivo. Int Immunopharmacol 3 (2003) 1-16
29. Sterzer P., Wiegers G.J., and Reul J.M. Long-term in vivo administration of glucocorticoid hormones attenuates their capacity to accelerate in vitro proliferation of rat splenic T cells. Endocrinology 145 (2004) 3630-3638
30. Zhang Q., Fong C.C., Zhang Y., Tzang C.H., Fong W.F., and Yang M. cDNA microarray analysis of the differentially expressed genes involved in murine pre-osteoclast RAW264.7 cells proliferation stimulated by dexamethasone. Life Sci 82 (2008) 135-148
31. Neuberger T.J., Kalimi O., Regelson W., Kalimi M., and De Vries G.H. Glucocorticoids enhance the potency of Schwann cell mitogens. J Neurosci Res 38 (1994) 300-313
32. Brion N., Pibarot M.L., Atienza P., Robin P., and Carbon C. Comparative serum pharmacokinetics of prednisone and prednisolone methylsulfobenzoate after oral administration. Presse Med 17 (1988) 569-571
33. Petersen K.B., Jusko W.J., Rasmussen M., and Schmiegelow K. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol 51 (2003) 465-473
34. Nykanen P., Raivio T., Heinonen K., Janne O.A., and Voutilainen R. Circulating glucocorticoid bioactivity and serum cortisol concentrations in premature infants: the influence of exogenous glucocorticoids and clinical factors. Eur J Endocrinol 156 (2007) 577-583
35. Laane E., Panaretakis T., Pokrovskaja K., Buentke E., Corcoran M., Soderhall S., et al. Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members. Haematologica 92 (2007) 1460-1469
36. Medh R.D., Saeed M.F., Johnson B.H., and Thompson E.B. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression. Cancer Res 58 (1998) 3684-3693
37. Morita K., Ishimura K., Tsuruo Y., and Wong D.L. Dexamethasone enhances serum deprivation-induced necrotic death of rat C6 glioma cells through activation of glucocorticoid receptors. Brain Res 816 (1999) 309-316
38. Lee J.M., Yan P., Xiao Q., Chen S., Lee K.Y., Hsu C.Y., et al. Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury. J Neurosci 28 (2008) 3141-3149
39. Fong C.C., Zhang Y., Zhang Q., Tzang C.H., Fong W.F., Wu R.S., et al. Dexamethasone protects RAW264.7 macrophages from growth arrest and apoptosis induced by H2O2 through alteration of gene expression patterns and inhibition of nuclear factor-kappa B (NF-kappaB) activity. Toxicology 236 (2007) 16-28
40. Wuerzberger-Davis S.M., Chang P.Y., Berchtold C., and Miyamoto S. Enhanced G2-M arrest by nuclear factor-{kappa}B-dependent p21waf1/cip1 induction. Mol Cancer Res 3 (2005) 345-353
41. Tonko M., Ausserlechner M.J., Bernhard D., Helmberg A., and Kofler R. Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid-induced apoptosis. FASEB J 15 (2001) 693-699
42. Tissing W.J., den Boer M.L., Meijerink J.P., Menezes R.X., Swagemakers S., van der Spek P.J., et al. Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells. Blood 109 (2007) 3929-3935
43. Kolla V., and Litwack G. Upregulation of mineralocorticoid- and glucocorticoid-receptor gene expression by Sp-I. Mol Cell Biol Res Commun 1 (1999) 44-47
44. Pirity M.K., Wang W.L., Wolf L.V., Tamm E.R., Schreiber-Agus N., and Cvekl A. Rybp, a polycomb complex-associated protein, is required for mouse eye development. BMC Dev Biol 7 (2007) 39
45. Lim G., Wang S., Zeng Q., Sung B., Yang L., and Mao J. Expression of spinal NMDA receptor and PKCgamma after chronic morphine is regulated by spinal glucocorticoid receptor. J Neurosci 25 (2005) 11145-11154
46. Fahnenstich J., Nandy A., Milde-Langosch K., Schneider-Merck T., Walther N., and Gellersen B. Promyelocytic leukaemia zinc finger protein (PLZF) is a glucocorticoid- and progesterone-induced transcription factor in human endometrial stromal cells and myometrial smooth muscle cells. Mol Hum Reprod 9 (2003) 611-623
47. Bailey S., Hall A.G., Pearson A.D., and Redfern C.P. The role of AP-1 in glucocorticoid resistance in leukaemia. Leukemia 15 (2001) 391-397
48. Li L.B., Leung D.Y., Strand M.J., and Goleva E. ATF2 impairs glucocorticoid receptor-mediated transactivation in human CD8+ T cells. Blood 110 (2007) 1570-1577
49. Geng C.D., Schwartz J.R., and Vedeckis W.V. A conserved molecular mechanism is responsible for the auto-upregulation of glucocorticoid receptor gene promoters. Mol Endocrinol 22 (2008) 2624-2642
50. Geng C.D., and Vedeckis W.V. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter. J Biol Chem 280 (2005) 43264-43271
51. Rulten S.L., Ripley T.L., Hunt C.L., Stephens D.N., and Mayne L.V. Sp1 and NFkappaB pathways are regulated in brain in response to acute and chronic ethanol. Genes Brain Behav 5 (2006) 257-273
52. Nicot C., Mahieux R., Pise-Masison C., Brady J., Gessain A., Yamaoka S., et al. Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage. Mol Cell Biol 21 (2001) 7391-7402
53. Geisler F., Algul H., Paxian S., and Schmid R.M. Genetic inactivation of RelA/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro. Gastroenterology 132 (2007) 2489-2503
54. de Pablos R.M., Villaran R.F., Arguelles S., Herrera A.J., Venero J.L., Ayala A., et al. Stress increases vulnerability to inflammation in the rat prefrontal cortex. J Neurosci 26 (2006) 5709-5719
55. Castro-Caldas M., Mendes A.F., Duarte C.B., and Lopes M.C. Dexamethasone-induced and estradiol-induced CREB activation and annexin 1 expression in CCRF-CEM lymphoblastic cells: evidence for the involvement of cAMP and p38 MAPK. Mediators Inflamm 12 (2003) 329-337
56. Caelles C., Gonzalez-Sancho J.M., and Munoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev 11 (1997) 3351-3364